Okami Medical Announces $45 Million Financing and New CEO Appointment to Drive Next Phase of Growth November 19, 2025 Okami Medical Announces $45 Million Financing and New CEO Appointment to Drive Next Phase of Growth Read More »
Okami Medical Announces Portfolio Expansion with the Addition of the SENDERO® MAX Delivery Catheter March 24, 2025 Okami Medical Announces Portfolio Expansion with the Addition of the SENDERO® MAX Delivery Catheter Read More »
Okami Medical Appoints Bill Hoffman to its Board of Directors December 3, 2024 Okami Medical Appoints Bill Hoffman to its Board of Directors Read More »
Okami Medical Announces Closing Of $32.5M Financing October 21, 2024 Okami Medical Announces Closing Of $32.5M Financing Read More »
Okami Medical Announces FDA 510(k) Clearance of the LOBO-7 and LOBO-9 Vascular Occluders To Address A Wide Range Of Peripheral Embolization Cases June 7, 2022 Okami Medical Announces FDA 510(k) Clearance of the LOBO-7 and LOBO-9 Vascular Occluders To Address A Wide Range Of Peripheral Embolization Cases Read More »
Okami Medical Announces FDA 510(k) Clearance of the LOBO-5 Vascular Occluder December 16, 2020 Okami Medical Announces FDA 510(k) Clearance of the LOBO-5 Vascular Occluder Read More »
